Louis Moore Bacon's CRL Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 48,925 shares of Charles River Laboratories International, Inc. (CRL) worth $7.65 M, representing 0.11% of the portfolio. First purchased in 2015-Q2, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Louis Moore Bacon has maintained a long-term strategic position in CRL, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2025, adding 27,438 shares. Largest reduction occurred in Q4 2024, reducing 50,513 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Louis Moore Bacon
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2015 | +65,000 | New Buy | 65,000 | $70.34 |
| Q3 2015 | -65,000 | Sold Out | 65,000 | $0.00 |
| Q4 2024 | +14,487 | New Buy | 14,487 | $184.60 |
| Q1 2025 | +27,438 | Add 189.40% | 41,925 | $150.52 |
| Q2 2025 | -15,116 | Reduce 36.05% | 26,809 | $151.73 |
| Q3 2025 | +22,116 | Add 82.49% | 48,925 | $156.46 |
Louis Moore Bacon's Charles River Laboratories International Investment FAQs
Louis Moore Bacon first purchased Charles River Laboratories International, Inc. (CRL) in Q2 2015, acquiring 65,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Charles River Laboratories International, Inc. (CRL) for 42 quarters since Q2 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's largest addition to Charles River Laboratories International, Inc. (CRL) was in Q2 2015, adding 65,000 shares worth $4.57 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 48,925 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $7.65 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.11% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's peak holding in Charles River Laboratories International, Inc. (CRL) was 65,000 shares, as reported at the end of Q2 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.